Premenstrual Syndromes : PMS and PMDD - Rutuja :: The site ...

68. Nielsen DA, Goldman D, Virkkunen M et al. Suicidality and
5-hydroxyindoleacetic acid concentration associated with a
tryptophan hydroxylase polymorphism. Arch Gen Psychiatry
1994; 51(1):34–8.
69. Bennett PJ, McMahon WM, Watabe J et al. Tryptophan hydroxylase
polymorphisms in suicide victims. Psychiatr Genet 2000;
10(1):13–17.
70. Geijer T, Frisch A, Persson ML et al. Search for association
between suicide attempt and serotonergic polymorphisms.
Psychiatr Genet 2000; 10(1):19–26.
71. Abbar M, Courtet P, Bellivier F et al. Suicide attempts and
the tryptophan hydroxylase gene. Mol Psychiatry 2001; 6(3):
268–73.
72. Bellivier F, Leroux M, Henry C et al. Serotonin transporter gene
polymorphism influences age at onset in patients with bipolar
affective disorder. Neurosci Lett 2002; 334(1):17–20.
73. Bellivier F, Henry C, Szoke A et al. Serotonin transporter gene
polymorphisms in patients with unipolar or bipolar depression.
Neurosci Lett 1998; 255(3):143–6.
74. Courtet P, Picot MC, Bellivier F et al. Serotonin transporter gene
may be involved in short-term risk of subsequent suicide
attempts. Biol Psychiatry 2004; 55(1):46–51.
75. Jonsson EG, Goldman D, Spurlock G et al. Tryptophan hydroxylase
and catechol-O-methyltransferase gene polymorphisms:
relationships to monoamine metabolite concentrations in CSF of
healthy volunteers. Eur Arch Psychiatry Clin Neurosci 1997;
247(6):297–302.
76. Serretti A, Zanardi R, Cusin C et al. Tryptophan hydroxylase
gene associated with paroxetine antidepressant activity. Eur
Neuropsychopharmacol 2001; 11(5):375–80.
77. Serretti A, Zanardi R, Rossini D et al. Influence of tryptophan
hydroxylase and serotonin transporter genes on fluvoxamine
antidepressant activity. Mol Psychiatry 2001; 6(5):586–92.
78. Serretti A, Cristina S, Lilli R et al. Family-based association
study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms
in mood disorders. Am J Med Genet 2002; 114(4):361–9.
79. Bellivier F, Chaste P, Malafosse A. Association between the
TPH gene A218C polymorphism and suicidal behavior: a metaanalysis.
Am J Med Genet B Neuropsychiatr Genet 2004;
124(1):87–91.
80. Manuck SB, Flory JD, Ferrell RE et al. Aggression and angerrelated
traits associated with a polymorphism of the tryptophan
hydroxylase gene. Biol Psychiatry 1999; 45(5):603–14.
81. Lalovic A, Turecki G. Meta-analysis of the association between
tryptophan hydroxylase and suicidal behavior. Am J Med Genet
2002; 114(5):533–40.
82. Magnay JL, Ismail KM, Chapman G et al. Serotonin transporter,
tryptophan hydroxylase, and monoamine oxidase A gene polymorphisms
in premenstrual dysphoric disorder. Am J Obstet
Gynecol 2006; 195(5):1254–9.
83. Zill P, Buttner A, Eisenmenger W, Bondy B, Ackenheil M.
Regional mRNA expression of a second tryptophan hydroxylase
isoform in postmortem tissue samples of two human brains. Eur
Neuropsychopharmacol 2004; 14(4):282–4.
84. Zhang X, Beaulieu JM, Gainetdinov RR, Caron MG. Functional
polymorphisms of the brain serotonin synthesizing enzyme tryptophan
hydroxylase-2. Cell Mol Life Sci 2006; 63(1):6–11.
85. Zill P, Buttner A, Eisenmenger W et al. Single nucleotide
polymorphism and haplotype analysis of a novel tryptophan
hydroxylase isoform (TPH2) gene in suicide victims. Biol
Psychiatry 2004; 56(8):581–6.
86. Zill P, Baghai TC, Zwanzger P et al. SNP and haplotype analysis
of a novel tryptophan hydroxylase isoform (TPH2) gene provide
evidence for association with major depression. Mol Psychiatry
2004; 9(11):1030–6.
GENETICS 169
87. Zhang X, Gainetdinov RR, Beaulieu JM et al. Loss-of-function
mutation in tryptophan hydroxylase-2 identified in unipolar
major depression. Neuron 2005; 45(1):11–16.
88. Heils A, Teufel A, Petri S et al. Allelic variation of human
serotonin transporter gene expression. J Neurochem 1996;
66(6):2621–4.
89. Auerbach J, Geller V, Lezer S et al. Dopamine D4 receptor
(D4DR) and serotonin transporter promoter (5-HTTLPR) polymorphisms
in the determination of temperament in 2-month-old
infants. Mol Psychiatry 1999; 4(4):369–73.
90. Beitchman JH, Baldassarra L, Mik H et al. Serotonin transporter
polymorphisms and persistent, pervasive childhood aggression.
Am J Psychiatry 2006; 163(6):1103–5.
91. Cadoret RJ, Langbehn D, Caspers K et al. Associations of the
serotonin transporter promoter polymorphism with aggressivity,
attention deficit, and conduct disorder in an adoptee population.
Compr Psychiatry 2003; 44(2):88–101.
92. Lesch KP, Bengel D, Heils A et al. Association of anxiety-related
traits with a polymorphism in the serotonin transporter gene
regulatory region. Science 1996; 274(5292):1527–31.
93. Serretti A, Benedetti F, Zanardi R, Smeraldi E. The influence of
Serotonin Transporter Promoter Polymorphism (SERTPR) and
other polymorphisms of the serotonin pathway on the efficacy
of antidepressant treatments. Prog Neuropsychopharmacol Biol
Psychiatry 2005; 29(6):1074–84.
94. Smith GS, Lotrich FE, Malhotra AK et al. Effects of serotonin
transporter promoter polymorphisms on serotonin function.
Neuropsychopharmacology 2004; 29(12):2226–34.
95. Lesch KP, Balling U, Gross J et al. Organization of the human
serotonin transporter gene. J Neural Transm Gen Sect 1994;
95(2):157–62.
96. MacKenzie A, Quinn J. A serotonin transporter gene intron 2
polymorphic region, correlated with affective disorders, has
allele-dependent differential enhancer-like properties in the mouse
embryo. Proc Natl Acad Sci USA 1999; 96(26):15251–5.
97. Beitchman JH, Davidge KM, Kennedy JL et al. The serotonin
transporter gene in aggressive children with and without ADHD
and nonaggressive matched controls. Ann NY Acad Sci 2003;
1008:248–51.
98. Fan JB, Sklar P. Meta-analysis reveals association between serotonin
transporter gene STin2 VNTR polymorphism and schizophrenia.
Mol Psychiatry 2005; 10(10):928–38, 891.
99. Battersby S, Ogilvie AD, Blackwood DH et al. Presence of multiple
functional polyadenylation signals and a single nucleotide
polymorphism in the 3� untranslated region of the human serotonin
transporter gene. J Neurochem 1999; 72(4):1384–8.
100. Kent L, Doerry U, Hardy E et al. Evidence that variation at the
serotonin transporter gene influences susceptibility to attention
deficit hyperactivity disorder (ADHD): analysis and pooled
analysis. Mol Psychiatry 2002; 7(8):908–12.
101. Mynett-Johnson L, Kealey C, Claffey E et al. Multimarker haplotypes
within the serotonin transporter gene suggest evidence of
an association with bipolar disorder. Am J Med Genet 2000;
96(6):845–9.
102. Melke J, Westberg L, Landen M et al. Serotonin transporter
gene polymorphisms and platelet [ 3 H] paroxetine binding in premenstrual
dysphoria. Psychoneuroendocrinology 2003; 28(3):
446–58.
103. Magnay JL, Ismail KM, Chapman G et al. Serotonin transporter,
tryptophan hydroxylase, and monoamine oxidase A gene polymorphisms
in premenstrual dysphoric disorder. Am J Obstet
Gynecol 2006; 195(5):1254–9.
104. Sabol SZ, Hu S, Hamer D. A functional polymorphism in the
monoamine oxidase A gene promoter. Hum Genet 1998;
103(3):273–9.